+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

South Africa Aesthetic Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • PDF Icon

    Report

  • 110 Pages
  • July 2026
  • Region: South Africa
  • Mordor Intelligence
  • ID: 6267685
The south africa aesthetic devices market size is expected to grow from USD 186.55 million in 2025 to USD 211.21 million in 2026 and is forecast to reach USD 393.17 million by 2031 at 13.22% CAGR over 2026-2031. This report is Segmented by Device Type (Energy-Based Devices, Non-Energy-Based Devices), Application (Skin Resurfacing & Tightening, Body Contouring & Cellulite Reduction, Hair Removal, Tattoo & Pigmentation Removal, Breast Augmentation, and More), and End User (Public & Private Hospitals, Specialty Aesthetic Clinics, Other End Users). The Market Forecasts are Provided in Terms of Value (USD).

South Africa Aesthetic Devices Market Trends and Insights

Increasing Awareness of Minimally-Invasive Cosmetic Procedures

Social media normalizes aesthetic enhancements and rapidly diffuses treatment knowledge. ISAPS data show that non-surgical procedures represented 56.5% of all South African aesthetic interventions in 2023, led by 29,643 botulinum-toxin injections and 12,641 hyaluronic-acid filler sessions. Celebrity endorsements reinforce safety perceptions, and tele-consultation apps widen specialist access for rural residents. Artificial-intelligence-guided treatment planning raises outcome predictability, addressing safety concerns. SAHPRA’s device-registration system ensures that only approved technologies reach clinics, further boosting patient confidence.

Rise in Skin Disorders & Obesity Prevalence

Environmental stressors and genetic predispositions heighten incidences of hyperpigmentation, keloids, and post-inflammatory scars among black South Africans, sharpening demand for pigment-safe lasers and intense-pulsed-light systems. Simultaneously, national obesity rates spur interest in non-invasive fat-reduction and skin-tightening devices. Emerging male-grooming brands tailored to black-male skin, such as locally developed lines targeting razor-bump complications, illustrate untapped product-adjacency opportunities. Medical-aid schemes increasingly recognize functional benefits of scar-revision therapies, supporting partial reimbursement for select devices.

Lack of Reimbursement; Out-of-Pocket Model

Full cash payment narrows access to advanced treatments, concentrating demand among affluent urbanites. Multi-session therapies such as cryolipolysis face higher patient-dropout risk due to cumulative cost. Although third-party financing products exist, high interest rates still deter middle-income consumers. Insurers seldom cover procedures even when functional benefits - for example, hyperhidrosis management - are clinically documented.

Other drivers and restraints analyzed in the detailed report include:

  • Growth in Medical Tourism Inflow
  • Expanding Disposable Income & Aspirational Spending
  • High Capital & Maintenance Cost of Advanced Devices

Segment Analysis

Non-energy-based products, led by botulinum toxin and dermal fillers, contributed 53.12% of the South Africa aesthetic devices market size in 2025 and remain the entry point for cost-conscious patients. Rapid-growing radio-frequency (RF) systems, however, are forecast to post a 16.58% CAGR as monopolar and bipolar platforms deliver visible tightening without incisions. AI-assisted ultrasound imaging is improving RF probe placement, elevating safety profiles. Portable diode lasers maintain popularity in mid-tier clinics because of versatile hair-removal and vascular-lesion settings. Top-end practices adopt hybrid RF-microneedling units that integrate depth-controlled needle cartridges, enhancing collagen remodeling while minimizing downtime. Emerging cryolipolysis and plasma-based resurfacing solutions find traction among patients seeking single-session body-sculpting or scar-revision options. SAHPRA’s impending device-registration regime could accelerate market consolidation by excluding substandard imports.

Energy-efficiency considerations shape capital-expenditure decisions; devices featuring sleep-mode and low-heat handpieces gain favor in load-shedding zones. Leasing models lower upfront cost barriers, allowing smaller clinics to trial premium lasers before full purchase. As competitive intensity rises, manufacturers bundle accreditation training and predictive-maintenance software, cementing brand loyalty. Secondary markets for refurbished lasers are expanding, offering entry-level providers a pathway into the South Africa aesthetic devices market without prohibitive capex.

Complete Report Scope:

  • By Device Type
    • Energy-based Devices
      • Laser-based
      • Light-based (IPL)
      • Radio-frequency-based
      • Ultrasound-based
      • Cryolipolysis & Plasma-based
    • Non-energy-based Devices
      • Botulinum Toxin
      • Dermal Fillers & Threads
      • Chemical Peels
      • Microdermabrasion
      • Implants
      • Mesotherapy & Others
  • By Application
    • Skin Resurfacing & Tightening
    • Body Contouring & Cellulite Reduction
    • Hair Removal
    • Tattoo & Pigmentation Removal
    • Breast Augmentation
    • Acne & Scar Treatment
    • Other Applications
  • By End User
    • Public & Private Hospitals
    • Specialty Aesthetic Clinics
    • Other End Users

List of Companies Covered in this Report:

  • Abbvie
  • Galderma
  • Boston Scientific (Lumenis)
  • Alma Lasers
  • Cynosure (Hologic)
  • Candela Medical
  • BTL
  • Venus Concept
  • Sciton
  • Cutera
  • Candela Medical
  • Fotona
  • Zimmer MedizinSystems
  • Lutronic
  • Sharplight Technologies
  • Jeisys Medical
  • SternLaser
  • Technolase
  • Laser Aesthetics SA

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Awareness of Minimally-Invasive Cosmetic Procedures
4.2.2 Rise in Skin Disorders & Obesity Prevalence
4.2.3 Growth in Medical Tourism Inflow
4.2.4 Expanding Disposable Income & Aspirational Spending
4.2.5 Surge in Male Aesthetic-Treatment Demand Post-Pandemic
4.2.6 Social-Media-Enabled Tele-Consult Platforms Extending Rural Reach
4.3 Market Restraints
4.3.1 Lack of Reimbursement; Out-of-Pocket Model
4.3.2 High Capital & Maintenance Cost of Advanced Devices
4.3.3 Electricity Load-Shedding Disrupting Device Uptime
4.3.4 Counterfeit Injectables Eroding Patient Trust
4.4 Regulatory Landscape
4.5 Technological Outlook
4.6 Porter’s Five Forces Analysis
4.6.1 Threat of New Entrants
4.6.2 Bargaining Power of Buyers
4.6.3 Bargaining Power of Suppliers
4.6.4 Threat of Substitutes
4.6.5 Intensity of Competitive Rivalry
5 Market Size & Growth Forecasts (Value in USD)
5.1 By Device Type
5.1.1 Energy-based Devices
5.1.1.1 Laser-based
5.1.1.2 Light-based (IPL)
5.1.1.3 Radio-frequency-based
5.1.1.4 Ultrasound-based
5.1.1.5 Cryolipolysis & Plasma-based
5.1.2 Non-energy-based Devices
5.1.2.1 Botulinum Toxin
5.1.2.2 Dermal Fillers & Threads
5.1.2.3 Chemical Peels
5.1.2.4 Microdermabrasion
5.1.2.5 Implants
5.1.2.6 Mesotherapy & Others
5.2 By Application
5.2.1 Skin Resurfacing & Tightening
5.2.2 Body Contouring & Cellulite Reduction
5.2.3 Hair Removal
5.2.4 Tattoo & Pigmentation Removal
5.2.5 Breast Augmentation
5.2.6 Acne & Scar Treatment
5.2.7 Other Applications
5.3 By End User
5.3.1 Public & Private Hospitals
5.3.2 Specialty Aesthetic Clinics
5.3.3 Other End Users
6 Competitive Landscape
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company Profiles (includes Global level Overview, Market-level Overview, Core Segments, Financials, Strategic Info, Market Rank/Share, Products & Services, Recent Developments)
6.3.1 AbbVie (Allergan Inc.)
6.3.2 Galderma
6.3.3 Boston Scientific (Lumenis)
6.3.4 Alma Lasers
6.3.5 Cynosure (Hologic)
6.3.6 Candela Medical
6.3.7 BTL Aesthetics
6.3.8 Venus Concept
6.3.9 Sciton
6.3.10 Cutera
6.3.11 Syneron Medical
6.3.12 Fotona
6.3.13 Zimmer MedizinSystems
6.3.14 Lutronic
6.3.15 Sharplight Technologies
6.3.16 Jeisys Medical
6.3.17 SternLaser
6.3.18 Technolase
6.3.19 Laser Aesthetics SA
7 Market Opportunities & Future Outlook
7.1 White-space & Unmet-need Assessment

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbbVie (Allergan Inc.)
  • Galderma
  • Boston Scientific (Lumenis)
  • Alma Lasers
  • Cynosure (Hologic)
  • Candela Medical
  • BTL Aesthetics
  • Venus Concept
  • Sciton
  • Cutera
  • Syneron Medical
  • Fotona
  • Zimmer MedizinSystems
  • Lutronic
  • Sharplight Technologies
  • Jeisys Medical
  • SternLaser
  • Technolase
  • Laser Aesthetics SA